Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 12, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$33.3B
sum of reported positions
Reported positions
403
Changes vs prior quarter
421
47 new · 57 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 299 measured positions in 8 quarters, the typical new or larger position finished −2.7 pts against the S&P 500 and 43% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 4.94M | $2.36B | 7.1% | |
| 8.6M | $1.72B | 5.2% | |
| 3.19M | $1.14B | 3.4% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $30.3B | $33.3B |
| Positions | 413 | 403 |
| Biggest line | — | Taiwan Semiconductor Manufacturing 7% |
| 3.26M |
| $943M |
| 2.8% |
| 2.06M | $777M | 2.3% |
| 2.05M | $764M | 2.3% |
| 950K | $535M | 1.6% |
| 1.99M | $474M | 1.4% |
| 918K | $471M | 1.4% |
| 764K | $444M | 1.3% |
| 498K | $360M | 1.1% |
| 791K | $296M | 0.9% |
| 1.51M | $283M | 0.9% |
| 11.4M | $279M | 0.8% |
| 3.46M | $272M | 0.8% |
| 1.54M | $271M | 0.8% |
| 505K | $262M | 0.8% |
| 665K | $252M | 0.8% |
| 3.78M | $251M | 0.8% |
| 5.91M | $249M | 0.7% |
| 265K | $245M | 0.7% |
| 1.99M | $244M | 0.7% |
| 2.54M | $244M | 0.7% |
| 586K | $244M | 0.7% |
| 625K | $244M | 0.7% |
Alphabet (GOOGL)
2.5M → 3.19M shares (+27%)
Applied Materials (AMAT)
35K → 498K shares (+1325%)
Everpure (P)
2.88M → 3.46M shares (+20%)
Amphenol (APH)
1.08M → 1.54M shares (+43%)
BorgWarner (BWA)
2.88M → 3.78M shares (+31%)
Curtiss-Wright (CW)
232K → 317K shares (+37%)
TEVA PHARMACEUTICAL INDS LTD
1.43M → 6.59M shares (+363%)
Regal Rexnord (RRX)
837K → 891K shares (+6%)
Krystal Biotech (KRYS)
407K → 570K shares (+40%)
Guardant Health (GH)
951K → 1.31M shares (+38%)
Cameco (CCJ)
1.68M → 1.86M shares (+11%)
Alignment Healthcare, Inc. (ALHC)
5.21M → 7.76M shares (+49%)
Diodes Incorporated (DIOD)
442K → 1.68M shares (+281%)
Bentley Systems (BSY)
3.32M → 5.94M shares (+79%)
Dynatrace (DT)
3.23M → 3.86M shares (+20%)
Mirum Pharmaceuticals (MIRM)
336K → 1.4M shares (+319%)
HealthEquity (HQY)
1.66M → 1.77M shares (+7%)
Texas Instruments (TXN)
424K → 506K shares (+19%)
West Pharmaceutical Services (WST)
40K → 417K shares (+951%)
Grand Canyon Education (LOPE)
980K → 1.04M shares (+6%)
Littelfuse (LFUS)
305K → 322K shares (+6%)
Totalenergies (TTE)
854K → 1.82M shares (+113%)
Timken (TKR)
5,176 → 955K shares (+18347%)
Cytokinetics (CYTK)
1.09M → 1.6M shares (+47%)
Birkenstock Holding (BIRK)
2.58M → 2.87M shares (+11%)